MedicineNet.com
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Health news and views MedTerms medical dictionary
Font Size
A
A
A


Medication Written by Pharmacists Reviewed by Doctors

Pharmacy Author: Omudhome Ogbru, PharmD
Medical and Pharmacy Editor: Jay W. Marks, MD

GENERIC NAME: gemfibrozil

BRAND NAMES: Lopid

DRUG CLASS AND MECHANISM: Gemfibrozil is a blood lipid and cholesterol-modifying medicine. It is classified as a fibric acid derivative similar to fenofibrate (Tricor). It reduces triglycerides and increases cholesterol carried in high density lipoprotein (HDL) in the blood. HDL cholesterol is sometimes called "good" cholesterol because higher concentrations of HDL cholesterol in the blood are associated with a reduced risk of heart disease. Gemfibrozil modestly reduces low density lipoprotein (LDL or "bad") cholesterol. The mechanism of action of gemfibrozil is not known. The decrease in triglycerides is thought to be due in part to reduced production of triglycerides by the liver. Lopid was approved in September 1993.

PRESCRIPTION: Yes

GENERIC AVAILABLE: Yes

PREPARATIONS: Tablets: 600 mg

STORAGE: Tablets should be stored at room temperature between 20 – 25 C (68 – 77 F).

PRESCRIBED FOR: Gemfibrozil is used for reducing elevated triglyceride levels that are high enough to cause pancreatitis. Because gemfibrozil raises HDL and decreases triglycerides it is prescribed for preventing coronary heart disease in individuals without a history or symptoms of coronary heart disease who have low HDL, high LDL and high triglycerides. Gemfibrozil is prescribed after other therapies have failed, and it is not intended for treating patients who only have low HDL. Gemfibrozil is used together with diet and exercise.

DOSING: The recommended dose of gemfibrozil is 600 mg 30 minutes before breakfast and dinner.

DRUG INTERACTIONS: Gemfibrozil, when used together with the statin family of cholesterol-reducing medications, for example, lovastatin (Mevacor), pravastatin (Pravachol), simvastatin (Zocor), fluvastatin (Lescol), rosuvastatin (Crestor), and atorvastatin (Lipitor) increases the risk of a condition called rhabdomyolysis (muscle injury) which when severe can lead to kidney damage and seven death. Rhabdomyolysis may occur as early as three weeks or several months after starting combination therapy. The benefit of combining gemfibrozil with statins does not outweigh the risk of rhabdomyolysis.

Gemfibrozil can increase the effect of warfarin (Coumadin) and thus may lead to bleeding. Therefore, patients on warfarin may need to have their doses of warfarin reduced when starting gemfibrozil.

Gemfibrozil increases blood levels of repaglinide (Prandin) in people with diabetes, increasing the likelihood of developing low blood sugar (hypoglycemia). This combination should be avoided.

Colestipol (Colestid) and cholestyramine (Questran) reduce the absorption of gemfibrozil and reduce its effectiveness if taken at the same time. Therefore, gemfibrozil should be administered one hour before or 4-6 hours after administering colestipol or cholestyramine.

PREGNANCY: The effect of gemfibrozil in pregnant women has not been well-studied. Gemfibrozil should be used during pregnancy only if the potential benefit justifies the unknown but potential risk to the fetus.

NURSING MOTHERS: It is not known whether gemfibrozil is excreted in human milk.

SIDE EFFECTS: Common side effects of gemfibrozil include upset stomach, stomach pain, diarrhea, headache, tiredness, nausea, and vomiting. Muscle aches and pain also occur. Rarely, these muscle-related symptoms are associated with damage to muscles that releases chemicals into the blood that that can damage the kidney. Muscle damage is of greatest concern when gemfibrozil is combined with statins. The formation of gallstones and gallbladder surgery have been associated with the use of gemfibrozil. Pancreatitis, abnormal blood liver tests, as well as reduced red blood cells (anemia), white blood cells (leukopenia) and blood platelets (thrombocytopenia) also have been reported.


Last Editorial Review: 3/26/2009




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • Fibrates - Fibrates are effective medications in lowering blood triglyceride levels to prevent heart disease.
  • Cholesterol - Learn about cholesterol and how to lower LDL cholesterol. Read in-depth cholesterol information on a low cholesterol diet, normal ratio (levels), treatment for high cholesterol and more.
  • Your Cholesterol Profile - In Depth - Cholesterol informaiton in-depth, mechanisms and mechanics of cholesterol plaque.

Latest Medical News


Back to Medications Index

Cholesterol Management

Tips to keep it under control.




Symptoms & Signs A-Z List Pinpoint Your Symptoms - Start Now Symptoms & Signs A-Z List Symptoms & Signs by Female Body Region Symptoms & Signs by Male Body Region

Topics Related to gemfibrozil, Lopid


gemfibrozil
RSS FeedSpecialty RSS       Add to My Yahoo! What is this?

Cholesterol GuidelinesCholesterol Guidelines
Think you know all there is to know about cholesterol? Learn the cholesterol guidelines: the good, bad, and that other one. See more WebMD Videos »



Related Drugs - WebMD Health Network











Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Search Help | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.